Feasibility and acceptability of HU-based treatment for children with Sickle Cell Disease in Niger

Feasibility and acceptability of HU-based treatment for children with Sickle Cell Disease in Niger

by Epicentre - MSF

Life & Natural Systems Medicine & Health MMedicine and NursingMJFHaematology
🎙 Epicentre - MSF 👥 737 📅 June 18, 2026 ⏱ 14 min 👁 19 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

Sickle Cell DiseaseHydroxyureaFeasibilityAcceptabilityQuality of Life

Summary

This video presents preliminary findings from two studies conducted by Epicentre/MSF on the feasibility and acceptability of hydroxyurea (HU) treatment for children with sickle cell disease (SCD) in rural Niger. The first study, a quantitative prospective assessment, evaluated quality of life in 30 children over 12 months using a validated questionnaire. Results showed significant improvement in quality of life scores from 67 to 90 out of 100, with notable improvements in pain, worries, and emotions. The second study, a qualitative investigation using semi-directed interviews with 49 participants (children, parents, healthcare professionals, and authorities), explored feasibility and acceptability. Participants reported high effectiveness of HU, reduced hospitalizations, improved pain management, and better socialization for children. Barriers included access to traditional medicine, community influence, fear of infertility, transportation costs, and medication formulation issues. The studies suggest that HU treatment is feasible and well-accepted in rural settings, with recommendations for community awareness, better pediatric formulations, capacity-building, and decentralization of care to scale up treatment.

160 words

Critical Evaluation

Value of the Information & Strength of the Argument

The video provides valuable insights into the real-world implementation of HU treatment for SCD in a low-resource setting. The argumentation is supported by preliminary data from both quantitative and qualitative studies, highlighting improvements in quality of life and treatment acceptability. However, the sample sizes are small, and the studies are not yet published, limiting the generalizability. The presentation is clear and structured, but the lack of detailed statistical analysis and potential biases are not discussed.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate: the studies are described with some methodological details, but the lack of peer review and limited sample sizes reduce confidence. The sources cited are primarily the presenters’ own research, with no external references provided in the description. The title accurately reflects the content, and the video is well-structured. No public comments were provided for analysis.

150 words

Title / Content Match

The title accurately reflects the content, focusing on feasibility and acceptability of hydroxyurea treatment for children with SCD in Niger.

Quality & Reliability

7/10

The video presents preliminary findings from a prospective quantitative study and a qualitative study conducted by Epicentre/MSF in Niger. The methodology is described (questionnaires, semi-directed interviews, thematic analysis), but details on sample sizes, statistical methods, and limitations are limited. The results are promising but not yet peer-reviewed.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Contribution & Novelties

This video contributes original data on the feasibility and acceptability of hydroxyurea treatment for sickle cell disease in a rural African setting, an area with limited evidence. It highlights improvements in quality of life and identifies key barriers and facilitators, offering practical recommendations for scaling up. The findings are preliminary but provide a foundation for future research and program implementation.

Pour aller plus loin :

107 words

Radar Profile

The radar profile shows balanced scores across information quantity, quality, technical level, and reliability, indicating a moderately comprehensive and reliable presentation. The strengths lie in the originality of the data and practical relevance, while limitations include small sample sizes and lack of peer review.

Reliability 7/10